search
Back to results

Efficacy of Acetaminophen in Posterior Fossa Surgery

Primary Purpose

Arnold-Chiari Malformation, Posterior Fossa Tumors

Status
Withdrawn
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
IV acetaminophen
normal saline
Sponsored by
Children's National Research Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Arnold-Chiari Malformation

Eligibility Criteria

2 Years - 12 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Any child undergoing posterior fossa surgery, including surgery for Chiari Malformation
  2. The subject's American Society of Anesthesiologists physical status is 1, 2 or 3
  3. Males and females 2 to 12 years old (minorities will be included) - recommended dosing of IV acetaminophen in children is approved for children 2 to 12 years of age
  4. Written informed consent from parent/guardian

Exclusion Criteria:

  1. Subjects with known or suspected hypersensitivity reaction to acetaminophen
  2. Presence or prior history of a known liver disease or coagulation disorder:
  3. History of abnormal liver function
  4. History of prior liver transplantation
  5. Subjects who are on anticoagulant therapy (Coumadin, heparin, aspirin, etc.)
  6. History of prior acetaminophen overdose
  7. Subjects with the need for mechanical ventilation prior to surgery or postoperatively - unable to assess accurate pain scores in this context
  8. The subject has a history or a family (parent or sibling) history of malignant hyperthermia
  9. The subject had a recent opioid exposure (within 1 month of surgery)
  10. The subject is obese (body mass index >30 kg/m2)
  11. The subject is an American Society of Anesthesiologist physical status classification of 4 or greater
  12. The subject is scheduled for a surgical sub-procedure
  13. Subjects who have been previously enrolled in this protocol may not be enrolled again

Sites / Locations

  • Children's National Health System

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

IV acetaminophen

normal saline

Arm Description

IV acetaminophen 15 mg/kg (1.5 mL/kg) IV loading dose prior to incision, followed by a 15 mg/kg (1.5 mL/kg) dose given every 6 hours for the first 24 hours after surgery (total of 4 doses postoperatively)

normal saline (placebo control) 1.5 mL/kg IV loading dose prior to incision, followed by a 1.5 mL/kg dose given every 6 hours for the first 24 hours after surgery (total of 4 doses postoperatively)

Outcomes

Primary Outcome Measures

Daily opioid consumption (mg/kg/24 hours using morphine equivalent)
Equianalgesic conversion of opioid consumption to morphine equivalent will be used

Secondary Outcome Measures

Average daily pain scores using Wong-Baker Faces or Numeric Pain Scale
Scores range from 0 [no pain] to 10 [worst possible pain]
Average daily sedation scores using University of Michigan Sedation Scale
Score range from 0 [completely awake] to 4 [asleep but not responsive to any stimuli]
Incidence of opioid-induced side effects
Incidence of postoperative nausea and vomiting (PONV) will be assessed by the need for rescue antiemetics (i.e. ondansetron or promethazine given as needed) Incidence and severity of pruritus will be assessed by the need for rescue anti-pruritic (i.e. diphenhydramine or hydroxyzine given as needed for pruritus)

Full Information

First Posted
August 21, 2015
Last Updated
April 3, 2021
Sponsor
Children's National Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT02532322
Brief Title
Efficacy of Acetaminophen in Posterior Fossa Surgery
Official Title
Efficacy of Intravenous Acetaminophen as Analgesic Adjuvant Therapy in Children Undergoing Posterior Fossa Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Withdrawn
Why Stopped
not enough patients meeting criteria
Study Start Date
November 2015 (undefined)
Primary Completion Date
June 2018 (Anticipated)
Study Completion Date
October 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Children's National Research Institute

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Uncontrolled pain after posterior fossa surgery and associated negative side effects of conventional opioid therapy causes significant morbidity and mortality in infants and children. Intravenous (IV) acetaminophen has been shown to be effective in treating mild to moderate pain, and moderate to severe pain in conjunction with adjuvant opioids in children. However, it is unknown if IV acetaminophen is effective as analgesic adjuvant therapy in children undergoing posterior fossa surgery. In this prospective, randomized controlled trial, the investigators aim to determine whether the addition of IV acetaminophen for 24 hours can lead to reduction in postoperative pain and opioid requirement after neurosurgical procedures of the posterior fossa compared with conventional therapy.
Detailed Description
The primary goal of this study is to compare the efficacy of IV acetaminophen to placebo in pediatric patients undergoing posterior fossa surgery, with the primary outcome measure being postoperative opioid requirements (morphine equivalent mg/kg). This will be a prospective, randomized, double blind control trial. The patient, research team, surgeon, and anesthesiologist will all be blinded to the patient's treatment group. Patients will receive either IV acetaminophen or equal volume normal saline (placebo) in the perioperative period. The interventional component of this study involves the intraoperative and postoperative administration of IV acetaminophen. Intraoperative and postoperative data pertaining to adverse events would be collected for safety monitoring purposes. Enrolled subjects will be randomized to receive either IV acetaminophen or equal volume saline placebo during surgery and for 24 hours postoperatively. According to a computer-generated table of random number assignments, each patient will be randomly assigned to receive one of the following two treatment groups: Treatment group 1: IV acetaminophen 15 mg/kg (1.5 mL/kg) IV loading dose prior to incision, followed by a 15 mg/kg (1.5 mL/kg) dose given every 6 hours for the first 24 hours after surgery (total of 4 doses postoperatively). This dosing regimen was chosen based on pharmacokinetic data and recommended dosing guidelines for IV acetaminophen in children 2 to 12 years of age. Treatment group 2: Equal volume of normal saline (placebo control) at the same dose and frequency as treatment group 1. Loading dose volumes and subsequent doses every 6 hours will be determined based on weight of the patient such that they will receive equal volumes of either IV acetaminophen or saline. Maintenance of anesthesia, including opioid administration, and perioperative management will proceed as per routine care. POSTOPERATIVE ANALGESIA At the completion of surgery, the anesthetic agents will be discontinued as per routine care. Per routine care, after tracheal extubation, morphine (0.05 mg/kg/dose) will be administered as needed by the blinded assessor until the patient appears comfortable, defined as the absence of any verbal or behavioral expression of pain. Patients will then be transferred to the intensive care unit (ICU). Time of entry into the intensive care unit will be recorded. The following assessments will be recorded at time of admission to the ICU: vital signs (heart rate, respiratory rate, blood pressure) oxygen saturation pain score sedation score As part of routine care for postoperative analgesia, patients will receive morphine sulfate at standard doses (0.05 - 0.1 mg/kg/dose every 3 hours as needed for pain). The frequency and dose of morphine will be adjusted according to the patient's pain score, with a goal to maintain a pain score of < 6. In addition, patients will transition to oral opioids as soon as their diet allows. The following parameters will be used to measure short-term postoperative analgesia and side effects: Daily opioid consumption (mg/kg/24h in morphine equivalent using the conversion) Pain scores at rest Sedation score The incidence of post-operative nausea and vomiting (PONV) will be assessed by the need for rescue antiemetics: i.e. ondansetron or promethazine given as needed. The incidence and severity of pruritus will be assessed by the need for rescue anti-pruritic: i.e. diphenhydramine or hydroxyzine given as needed for pruritus The incidence of pyrexia (defined as core temperature ≥ 38º Celsius). Ketorolac will be administered 0.5 mg/kg q6h prn as needed for pyrexia as per routine care. Data collection will continue for up to 72 hours postoperatively. DATA ANALYSIS Data will be analyzed to determine the decrease in postoperative opioid requirements with or without IV acetaminophen after posterior fossa surgery as the primary outcome. The investigators hypothesize that IV acetaminophen will decrease postoperative opioid requirements, pain and sedation scores, and opioid-induced side effects in children undergoing posterior fossa surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Arnold-Chiari Malformation, Posterior Fossa Tumors

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
IV acetaminophen
Arm Type
Experimental
Arm Description
IV acetaminophen 15 mg/kg (1.5 mL/kg) IV loading dose prior to incision, followed by a 15 mg/kg (1.5 mL/kg) dose given every 6 hours for the first 24 hours after surgery (total of 4 doses postoperatively)
Arm Title
normal saline
Arm Type
Placebo Comparator
Arm Description
normal saline (placebo control) 1.5 mL/kg IV loading dose prior to incision, followed by a 1.5 mL/kg dose given every 6 hours for the first 24 hours after surgery (total of 4 doses postoperatively)
Intervention Type
Drug
Intervention Name(s)
IV acetaminophen
Other Intervention Name(s)
Tylenol, APAP
Intervention Description
IV acetaminophen 15 mg/kg (1.5 mL/kg) IV loading dose prior to incision, followed by a 15 mg/kg (1.5 mL/kg) dose given every 6 hours for the first 24 hours after surgery (total of 4 doses postoperatively)
Intervention Type
Drug
Intervention Name(s)
normal saline
Other Intervention Name(s)
saline placebo, NS 0.9%
Intervention Description
normal saline 1.5 mL/kg IV loading dose prior to incision, followed by a 1.5 mL/kg dose given every 6 hours for the first 24 hours after surgery (total of 4 doses postoperatively)
Primary Outcome Measure Information:
Title
Daily opioid consumption (mg/kg/24 hours using morphine equivalent)
Description
Equianalgesic conversion of opioid consumption to morphine equivalent will be used
Time Frame
72 hours postoperatively
Secondary Outcome Measure Information:
Title
Average daily pain scores using Wong-Baker Faces or Numeric Pain Scale
Description
Scores range from 0 [no pain] to 10 [worst possible pain]
Time Frame
72 hours postoperatively
Title
Average daily sedation scores using University of Michigan Sedation Scale
Description
Score range from 0 [completely awake] to 4 [asleep but not responsive to any stimuli]
Time Frame
72 hours postoperatively
Title
Incidence of opioid-induced side effects
Description
Incidence of postoperative nausea and vomiting (PONV) will be assessed by the need for rescue antiemetics (i.e. ondansetron or promethazine given as needed) Incidence and severity of pruritus will be assessed by the need for rescue anti-pruritic (i.e. diphenhydramine or hydroxyzine given as needed for pruritus)
Time Frame
72 hours postoperatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Any child undergoing posterior fossa surgery, including surgery for Chiari Malformation The subject's American Society of Anesthesiologists physical status is 1, 2 or 3 Males and females 2 to 12 years old (minorities will be included) - recommended dosing of IV acetaminophen in children is approved for children 2 to 12 years of age Written informed consent from parent/guardian Exclusion Criteria: Subjects with known or suspected hypersensitivity reaction to acetaminophen Presence or prior history of a known liver disease or coagulation disorder: History of abnormal liver function History of prior liver transplantation Subjects who are on anticoagulant therapy (Coumadin, heparin, aspirin, etc.) History of prior acetaminophen overdose Subjects with the need for mechanical ventilation prior to surgery or postoperatively - unable to assess accurate pain scores in this context The subject has a history or a family (parent or sibling) history of malignant hyperthermia The subject had a recent opioid exposure (within 1 month of surgery) The subject is obese (body mass index >30 kg/m2) The subject is an American Society of Anesthesiologist physical status classification of 4 or greater The subject is scheduled for a surgical sub-procedure Subjects who have been previously enrolled in this protocol may not be enrolled again
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Srijaya K Reddy, MD, MBA
Organizational Affiliation
Children's National Health System
Official's Role
Principal Investigator
Facility Information:
Facility Name
Children's National Health System
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20010
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
8837797
Citation
De Benedittis G, Lorenzetti A, Migliore M, Spagnoli D, Tiberio F, Villani RM. Postoperative pain in neurosurgery: a pilot study in brain surgery. Neurosurgery. 1996 Mar;38(3):466-9; discussion 469-70. doi: 10.1097/00006123-199603000-00008.
Results Reference
background
PubMed Identifier
22156333
Citation
Morad A, Winters B, Stevens R, White E, Weingart J, Yaster M, Gottschalk A. The efficacy of intravenous patient-controlled analgesia after intracranial surgery of the posterior fossa: a prospective, randomized controlled trial. Anesth Analg. 2012 Feb;114(2):416-23. doi: 10.1213/ANE.0b013e31823f0c5a. Epub 2011 Dec 9.
Results Reference
background
PubMed Identifier
24654353
Citation
Baley K, Michalov K, Kossick MA, McDowell M. Intravenous acetaminophen and intravenous ketorolac for management of pediatric surgical pain: a literature review. AANA J. 2014 Feb;82(1):53-64.
Results Reference
background
PubMed Identifier
16895621
Citation
Alhashemi JA, Daghistani MF. Effect of intraoperative intravenous acetaminophen vs. intramuscular meperidine on pain and discharge time after paediatric dental restoration. Eur J Anaesthesiol. 2007 Feb;24(2):128-33. doi: 10.1017/S0265021506001232. Epub 2006 Aug 8.
Results Reference
background
PubMed Identifier
16613928
Citation
Alhashemi JA, Daghistani MF. Effects of intraoperative i.v. acetaminophen vs i.m. meperidine on post-tonsillectomy pain in children. Br J Anaesth. 2006 Jun;96(6):790-5. doi: 10.1093/bja/ael084. Epub 2006 Apr 13.
Results Reference
background
PubMed Identifier
12351250
Citation
Lahtinen P, Kokki H, Hendolin H, Hakala T, Hynynen M. Propacetamol as adjunctive treatment for postoperative pain after cardiac surgery. Anesth Analg. 2002 Oct;95(4):813-9, table of contents. doi: 10.1097/00000539-200210000-00005.
Results Reference
background

Learn more about this trial

Efficacy of Acetaminophen in Posterior Fossa Surgery

We'll reach out to this number within 24 hrs